drugset / Trial / NCT01958814

Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.

NCT01958814

Phase 2 Completed 43 enrolled University Hospital, Tours
RandomizedParallel-groupDouble-blindTreatment

Summary

randomized double-blind controlled study in parallel groups Salbutamol is a β2 mimetic short-acting to be administered by nebulization in this study. During this administration, non invasive ventilation for the patient will be continued.

Timeline

Start
2012-02
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Salbutamol Unknown 5 mg Other

Indications